Ipamorelin 5mg

Ipamorelin is an investigational synthetic pentapeptide and a selective growth hormone secretagogue (GHS). It belongs to a class of compounds that stimulate the natural release of growth hormone (GH) from the pituitary gland. Unlike some other GHS peptides, Ipamorelin is noted for its high selectivity for GH release, with minimal impact on other hormones such as prolactin, cortisol, and adrenocorticotropic hormone (ACTH), even at doses significantly higher than those required to induce GH secretion.

Mechanism of Action

Ipamorelin primarily functions by mimicking ghrelin, a naturally occurring peptide that binds to the growth hormone secretagogue receptor (GHSR-1a) in the brain. This binding stimulates the pituitary gland to release growth hormone in a pulsatile manner, similar to the body's natural physiological secretion patterns. Its selectivity means it avoids the appetite-stimulating effects associated with some ghrelin mimetics, making it a subject of research for specific growth hormone-related investigations without confounding factors.

Structure and Class

Chemically, Ipamorelin is a linear pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. Its small molecular size is characteristic of many synthetic peptides in this research class. The inclusion of non-natural amino acids, such as alpha-aminoisobutyric acid (Aib) and D-2-naphthylalanine (D-2-Nal), contributes to its stability and pharmacological profile, enhancing its binding affinity and efficacy as a GH secretagogue.

Research Areas and Findings

Research into Ipamorelin has focused on its potential in areas such as growth hormone deficiency, muscle growth, bone density, and metabolic regulation within investigational models. Preclinical studies have shown that Ipamorelin can increase lean body mass and reduce body fat when administered over extended periods. Researchers are also exploring its role in accelerating wound healing and recovery from injury, due to growth hormone's known regenerative properties. Its selective action is a key aspect for studies aiming to isolate the specific effects of GH release without significant off-target effects on other endocrine systems.